This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hansen Medical's CEO Discusses Q2 2012 Results - Earnings Call Transcript

And with that, I will turn the call over to Bruce.

Bruce Barclay

Thanks Pete good afternoon everyone. Thank you all for joining us today for our second quarter 2012 conference call. Today’s call will consist of an update on the initial commercial launch of our Magellan Robotic System with particular emphasis on our US launch, a discussion of our achievements for the second quartet, a review of the EP business and lastly a look at our plans for the remainder of 2012 and beyond. I will then turn the call over to Pete, who will provide a review of our financial results for the quarter. Pete and I will then take your questions at the conclusion of our prepared remarks.

But before we get to our review of the business, we are fortunate to have on the phone with us today from Europe Professor Nick Cheshire, M.D. of St. Mary's Hospital part of the Imperial College Healthcare NHS Trust in London, an academic health science center. Professor Cheshire is also head of Circulation Science at Imperial College Healthcare. Under Professor Cheshire’s direction, multiple physician disciplines including vascular surgery and interventional radiology have been pioneering the use of intravascular robotic.

St. Mary’s was the first hospital in the world to have a Magellan Robotic System and to begin successfully treating patients with it. As a reminder, Professor Cheshire is an Independent Clinician and Professor of Medicine and has no direct affiliation with Hansen Medical. Professor Cheshire will speak today on his experiences with the Hansen Medical intravascular robotics technology in both preclinical and clinical settings, the benefits he has seen to patients and his hospital using this system and his views on the potential value of intravascular robotic.

Professor Cheshire first let me thank you for letting us interrupt your holiday with your family and for joining us for what is very late in the day in Europe. Please go ahead when you are ready.

Nick Cheshire

Thank you Bruce and good evening everyone. I have a number of comments to make and I will address them under several headings.

Read the rest of this transcript for free on

3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.18 0.58%
FB $117.98 -0.50%
GOOG $695.88 -0.33%
TSLA $233.74 -3.30%
YHOO $36.05 -1.30%


Chart of I:DJI
DOW 17,701.19 -189.97 -1.06%
S&P 500 2,058.43 -23.00 -1.10%
NASDAQ 4,759.1050 -58.4890 -1.21%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs